85 FR 36 pgs. 10464-10466 - Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC
Type: NOTICEVolume: 85Number: 36Pages: 10464 - 10466
Pages: 10464, 10465Docket number: [Docket No. DEA-584]
FR document: [FR Doc. 2020-03616 Filed 2-21-20; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-584]
Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 24, 2020.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on December 9, 2019, Synthcon, LLC, 770 Wooten Road, Suite 101, Colorado Springs, Colorado 80915-3538 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
[top]
Controlled substance | Drug code | Schedule |
---|---|---|
Amphetamine | 1100 | II |
Methamphetamine | 1105 | II |
3-Fluoro-N-methylcathinone (3-FMC) | 1233 | I |
Cathinone | 1235 | I |
Methcathinone | 1237 | I |
4-Fluoro-N-methylcathinone (4-FMC) | 1238 | I |
Pentedrone (a-methylaminovalerophenone) | 1246 | I |
Mephedrone (4-Methyl-N-methylcathinone) | 1248 | I |
4-Methyl-N-ethylcathinone (4-MEC) | 1249 | I |
Naphyrone | 1258 | I |
N-Ethylamphetamine | 1475 | I |
N,N-Dimethylamphetamine | 1480 | I |
Aminorex | 1585 | I |
4-Methylaminorex (cis isomer) | 1590 | I |
Gamma Hydroxybutyric Acid | 2010 | I |
Methaqualone | 2565 | I |
Mecloqualone | 2572 | I |
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) | 6250 | I |
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) | 7035 | I |
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) | 7118 | I |
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) | 7173 | I |
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) | 7200 | I |
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) | 7203 | I |
Alpha-ethyltryptamine | 7249 | I |
Ibogaine | 7260 | I |
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) | 7297 | I |
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) | 7298 | I |
Lysergic acid diethylamide | 7315 | I |
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) | 7348 | I |
Tetrahydrocannabinols | 7370 | I |
Mescaline | 7381 | I |
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) | 7385 | I |
3,4,5-Trimethoxyamphetamine | 7390 | I |
4-Bromo-2,5-dimethoxyamphetamine | 7391 | I |
4-Bromo-2,5-dimethoxyphenethylamine | 7392 | I |
4-Methyl-2,5-dimethoxyamphetamine | 7395 | I |
2,5-Dimethoxyamphetamine | 7396 | I |
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) | 7398 | I |
2,5-Dimethoxy-4-ethylamphetamine | 7399 | I |
3,4-Methylenedioxyamphetamine | 7400 | I |
5-Methoxy-3,4-methylenedioxyamphetamine | 7401 | I |
N-Hydroxy-3,4-methylenedioxyamphetamine | 7402 | I |
3,4-Methylenedioxy-N-ethylamphetamine | 7404 | I |
3,4-Methylenedioxymethamphetamine | 7405 | I |
4-Methoxyamphetamine | 7411 | I |
5-Methoxy-N-N-dimethyltryptamine | 7431 | I |
Alpha-methyltryptamine | 7432 | I |
Bufotenine | 7433 | I |
Diethyltryptamine | 7434 | I |
Dimethyltryptamine | 7435 | I |
Psilocybin | 7437 | I |
Psilocyn | 7438 | I |
5-Methoxy-N,N-diisopropyltryptamine | 7439 | I |
N-Ethyl-1-phenylcyclohexylamine | 7455 | I |
1-(1-Phenylcyclohexyl)pyrrolidine | 7458 | I |
1-Phenylcyclohexylamine | 7460 | II |
1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I |
Phencyclidine | 7471 | II |
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine | 7473 | I |
N-Ethyl-3-piperidyl benzilate | 7482 | I |
N-Methyl-3-piperidyl benzilate | 7484 | I |
N-Benzylpiperazine | 7493 | I |
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) | 7498 | I |
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) | 7508 | I |
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) | 7509 | I |
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) | 7517 | I |
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) | 7518 | I |
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) | 7519 | I |
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) | 7521 | I |
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) | 7524 | I |
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4 ) | 7532 | I |
MDPV (3,4-Methylenedioxypyrovalerone) | 7535 | I |
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) | 7536 | I |
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) | 7537 | I |
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) | 7538 | I |
Methylone (3,4-Methylenedioxy-N-methylcathinone) | 7540 | I |
Butylone | 7541 | I |
Pentylone | 7542 | I |
alpha-pyrrolidinopentiophenone (a-PVP) | 7545 | I |
alpha-pyrrolidinobutiophenone (a-PBP) | 7546 | I |
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) | 7694 | I |
4-Anilino-N-phenethyl-4-piperidine (ANPP) | 8333 | II |
Phenylacetone | 8501 | II |
1-Piperidinocyclohexanecarbonitrile | 8603 | II |
Alphaprodine | 9010 | II |
Anileridine | 9020 | II |
Cocaine | 9041 | II |
Etorphine (except HCl) | 9056 | I |
Diphenoxylate | 9170 | II |
Ecgonine | 9180 | II |
Heroin | 9200 | I |
Levorphanol | 9220 | II |
Meperidine | 9230 | II |
Meperidine intermediate-A | 9232 | II |
Meperidine intermediate-B | 9233 | II |
Meperidine intermediate-C | 9234 | II |
Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II |
Morphine | 9300 | II |
Normorphine | 9313 | I |
Acetorphine | 9319 | I |
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) | 9547 | I |
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) | 9551 | I |
Acetylmethadol | 9601 | I |
Allylprodine | 9602 | I |
Alphacetylmethadol except levo-alphacetylmethadol | 9603 | I |
Alphameprodine | 9604 | I |
Alphamethadol | 9605 | I |
Benzethidine | 9606 | I |
Betacetylmethadol | 9607 | I |
Clonitazene | 9612 | I |
Diampromide | 9615 | I |
Diethylthiambutene | 9616 | I |
Dimethylthiambutene | 9619 | I |
Ketobemidone | 9628 | I |
Levo-alphacetylmethadol | 9648 | II |
1-Methyl-4-phenyl-4-propionoxypiperidine | 9661 | I |
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine | 9663 | I |
Alfentanil | 9737 | II |
Remifentanil | 9739 | II |
Sufentanil | 9740 | II |
Carfentanil | 9743 | II |
Tilidine | 9750 | I |
Tapentadol | 9780 | II |
Fentanyl | 9801 | II |
Para-Fluorofentanyl | 9812 | I |
3-Methylfentanyl | 9813 | I |
Alpha-methylfentanyl | 9814 | I |
Acetyl-alpha-methylfentanyl | 9815 | I |
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 | I |
Beta-hydroxyfentanyl | 9830 | I |
Beta-hydroxy-3-methylfentanyl | 9831 | I |
Alpha-methylthiofentanyl | 9832 | I |
3-Methylthiofentanyl | 9833 | I |
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) | 9834 | I |
Thiofentanyl | 9835 | I |
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide | 9843 | I |
Cyclopropyl Fentanyl | 9845 | I |
Fentanyl related-compounds as defined in 21 CFR 1308.11&h) | 9850 | I |
The company plans to manufacture the above-listed controlled substances as analytical reference standards for distribution to its customers. No other activities for these drug codes are authorized for this registration.
Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-03616 Filed 2-21-20; 8:45 am]
BILLING CODE 4410-09-P